Emzor raises N26.7bn bond to boost local drug manufacturing
Summarized by DistantNews. Read the original for the full story.
At a glance
News
Named sources
New plan
- Emzor Pharmaceutical Industries raised a 19.8 million dollar, 26.7 billion naira Series 1 fixed-rate bond on the FMDQ Group Exchange.
- The financing will support local drug manufacturing and the completion of West Africa’s first full-scale anti-malarial active pharmaceutical ingredient facility.
Emzor Pharmaceutical Industries has raised a 19.8 million dollar, 26.7 billion naira Series 1 fixed-rate bond on the FMDQ Group Exchange.
The company will use the financing to strengthen local pharmaceutical manufacturing and complete what it described as West Africa’s first full-scale facility for producing anti-malarial active pharmaceutical ingredients.
About this summary
Originally published by Vanguard. Summarized and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.
More Stories
From Our Blog
How the Same Story Looks Different in Different Countries
What Gets Lost (and Found) When News Is Translated
The Critical Role of Diaspora Media in Global News
What Travellers Should Know About Countries with Restricted Press
A Digital Nomad's Guide to Following Local News
